Business Segments · Depreciation

Life Sciences and Diagnostics Markets — Depreciation

Agilent Technologies Life Sciences and Diagnostics Markets — Depreciation increased by 13.0% to $26.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 13.0%, from $23.00M to $26.00M.

Analysis

StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ4 2022
Last reportedQ4 2025
Rolls up toD&A

How to read this metric

Increasing depreciation may signal significant recent capital investment in new equipment, while stable levels indicate a consistent asset base.

Detailed definition

This is the systematic allocation of the cost of tangible assets, such as manufacturing equipment and laboratory facilit...

Peer comparison

Standard non-cash expense metric for capital-intensive businesses.

Metric ID: a_segment_life_sciences_and_diagnostics_markets_depreciation

Historical Data

10 periods
 Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q4 '25
Value$15.00M$15.00M$15.00M$15.00M$18.00M$18.00M$18.00M$18.00M$23.00M$26.00M
QoQ Change+0.0%+0.0%+0.0%+20.0%+0.0%+0.0%+0.0%+27.8%+13.0%
YoY Change+20.0%+20.0%+20.0%+20.0%+27.8%+13.0%
Range$15.00M$26.00M
CAGR+27.7%
Avg YoY Growth+20.1%
Median YoY Growth+20.0%
Current Streak9+ quarters growth

Frequently Asked Questions

What is Agilent Technologies's life sciences and diagnostics markets — depreciation?
Agilent Technologies (A) reported life sciences and diagnostics markets — depreciation of $26.00M in Q4 2025.
How has Agilent Technologies's life sciences and diagnostics markets — depreciation changed year-over-year?
Agilent Technologies's life sciences and diagnostics markets — depreciation increased by 13.0% year-over-year, from $23.00M to $26.00M.
What does life sciences and diagnostics markets — depreciation mean?
The periodic expense representing the wear and tear of physical assets used by the segment.